(IN BRIEF) YURiA-PHARM, a leading Ukrainian pharma company, has acquired Reka-Med, a pharmaceutical company in Uzbekistan, with the help of €10 million of finance repurposed from an existing loan made by the European Bank for Reconstruction and Development (EBRD). The … Read the full press release
Posted in Banks, Business, Economy, Financial, Industrial, Investment, Management, News, Pharma & Biotech, United Kingdom
Tagged ACQUIRES, EBRD, financing, Matteo Patrone, Reka-Med, UK, UKRAINE, Uzbekistan, YURiA-PHARM
AN INTERNATIONAL COLLABORATION OF HIGH-PROFILE EXPERTS DEFINED READY-TO-UPSCALE GREEN CHEMICALS AND TECHNOLOGIES FOR THE WOOD-TO-TEXTILE VALUE CHAIN (IN BRIEF)The GRETE project, an international collaboration of experts aimed at reducing the environmental footprint of the textile industry, presented their achievements to … Read the full press release
Posted in Apparel, Fashion & Beauty, Automotive, Chemicals, Commodities, Economy, Education, Electronics & Machinery, Energy, Gas & Oil, Environment, Government, Industrial, Infrastructure & Utilities, Pharma & Biotech, Science, Technology
Tagged 4th Cellulose Fibres Conference, bio based industry, bio based materials, cellulose dissolution, cellulose fibre, green chemicals, green industry, GRETE, ionic liquids, kraft pulp, Materially S.r.l., Metsä Group, novel liquid salts, process innovation, regenerated cellulose, solvent systems, sustainable textiles, textile fibres, textile industry, wood pulp modification, wood to textile
(IN BRIEF) Roche has announced a collaboration with Eli Lilly to support the development of its Elecsys Amyloid Plasma Panel (EAPP) which is an innovative blood test that aims to facilitate the earlier diagnosis of Alzheimer’s disease. The EAPP test … Read the full press release
(IN BRIEF) Bayer has launched a new water strategy at the UN 2023 Water Conference in New York, which aims to make water an integral part of its business decisions, investments, and supplier selection. The strategy reflects the company’s role … Read the full press release
Posted in Agriculture, Chemicals, Environment, Germany, Healthcare, Management, News, Pharma & Biotech, Technology
Tagged agriculture, Bayer, Corporate Water Stewardship, Cristina Alonso Alija, health, Werner Baumann
(IN BRIEF) BioNTech and OncoC4 have entered into an exclusive license and collaboration agreement to develop and commercialize OncoC4’s anti-CTLA-4 monoclonal antibody candidate, ONC-392. The candidate aims to delete immunosuppressive T cells in the tumor microenvironment but spare T cells … Read the full press release
Posted in Germany, Management, News, Pharma & Biotech, Science, Technology
Tagged anti-CTLA-4 monoclonal antibody, BioNTech, Germany, ONC-392, OncoC4, Prof. Ugur Sahin, T cells, Yang Liu
(IN BRIEF) I am excited to share that XSpline SPA and Ordensklinikum Linz Elisabethinen Hospital have enrolled the first patient in the CRT-DRIVE clinical trial. Our cloud-based XSpline Cloud technology offers non-invasive cardiac panoramic mapping to select individual CRT treatment … Read the full press release
Posted in Artificial Intelligence (AI), Austria, Healthcare, Italy, News, Pharma & Biotech, Science, Technology
Tagged 3D panoramic electro-anatomical map, AI, artificial-intelligence, Austria, automatic segmentation coronary sinus, Bolzano, cardiac resynchronization therapy, cardiac structures, clinical study, Cloud, cloud platform, coronary sinus veins, CRT, CRT implantation, CRT treatment, CRT-DRIVE, d endocardial segmentation, DICOM, DICOM viewer, Dr. Georgios Kollias M.D., ECG, EF LV, electro- anatomical maps, epi, ESV LV, HL7 FIHR, IHE profiles, Italy, LV=, Mr. Werner Rainer, non-invasive cardiac panoramic mapping, non-invasive electrical, non-invasive electrical activation map, Ordensklinikum Linz Elisabethinen Hospital in Linz, start-up, University of Linz, venous anatomy assessment, XSpline Cloud, XSpline SPA
(IN BRIEF) Dr. Georgios Kollias, the principal investigator for the clinical trial in Austria, expressed great satisfaction with the XSpline Cloud software, a non-invasive cardiac panoramic mapping technology designed to select individual CRT treatment strategies and predict outcomes. As the … Read the full press release
Posted in Artificial Intelligence (AI), Austria, Healthcare, Italy, News, Pharma & Biotech, Science, Technology
Tagged 3D panoramic electro-anatomical map, AI, artificial-intelligence, Austria, automatic segmentation coronary sinus, Bolzano, cardiac resynchronization therapy, cardiac structures, clinical study, Cloud, cloud platform, coronary sinus veins, CRT, CRT implantation, CRT treatment, CRT-DRIVE, d endocardial segmentation, DICOM, DICOM viewer, Dr. Georgios Kollias M.D., ECG, EF LV, electro- anatomical maps, epi, ESV LV, HL7 FIHR, IHE profiles, Italy, LV=, Mr. Werner Rainer, non-invasive cardiac panoramic mapping, non-invasive electrical, non-invasive electrical activation map, Ordensklinikum Linz Elisabethinen Hospital in Linz, start-up, University of Linz, venous anatomy assessment, XSpline Cloud, XSpline SPA
XSpline Cloud: First-in-class cloud platform for personalized cardiac resynchronization therapy evaluated in International Clinical Trial; first procedure performed at the Ordensklinikum Linz Elisabethinen Hospital (Austria). (IN BRIEF) XSpline SPA, an Italian start-up company, and the Ordensklinikum Linz Elisabethinen Hospital in … Read the full press release
Posted in Austria, Healthcare, Italy, News, Pharma & Biotech, Science, Technology
Tagged 3D panoramic electro-anatomical map, AI, artificial intelligence, Austria, automatic segmentation coronary sinus, Bolzano, cardiac resynchronization therapy, cardiac structures, clinical study, Cloud, cloud platform, coronary sinus veins, CRT, CRT implantation, CRT treatment, CRT-DRIVE, d endocardial segmentation, DICOM, DICOM viewer, Dr. Georgios Kollias M.D., ECG, EF LV, electro- anatomical maps, epi, ESV LV, HL7 FIHR, IHE profiles, Italy, LV, Mr. Werner Rainer, non-invasive cardiac panoramic mapping, non-invasive electrical, non-invasive electrical activation map, Ordensklinikum Linz Elisabethinen Hospital in Linz, start-up, University of Linz, venous anatomy assessment, XSpline Cloud, XSpline SPA
(NOTICIA EN BREVE) El congreso científico EHRA 2023 de la European Heart Rhythm Association (EHRA), una rama de la Sociedad Europea de Cardiología (ESC), se llevará a cabo del 16 al 18 de abril en Barcelona, España, así como en … Read the full press release
Posted in Education, France, Healthcare, Management, Pharma & Biotech, Science, Spain, Technology
Tagged Asociación Europea del Ritmo Cardíaco, carga de coches eléctricos, control del ritmo cardíaco, dispositivos cardíacos, EHRA, EHRA 2023, ESC, estatinas, fibrilación auricular, IA, Inteligencia artificial, Profesor Andrea Sarkozy, Profesor Serge Boveda, Sociedad Europea de Cardiología, trastornos del ritmo cardíaco
(IN BRIEF) The EHRA 2023 scientific congress of the European Heart Rhythm Association (EHRA), a branch of the European Society of Cardiology (ESC), will be held from April 16 to 18 in Barcelona, Spain, as well as online. The congress … Read the full press release
Posted in Artificial Intelligence (AI), Education, France, Healthcare, Management, Pharma & Biotech, Science, Spain, Technology
Tagged AI, artificial-intelligence, atrial fibrillation, cardiac devices, charging of electric cars, EHRA, EHRA 2023, ESC, European Heart Rhythm Association, European Society of Cardiology, heart rhythm disorders, heart rhythm management, Professor Andrea Sarkozy, Professor Serge Boveda, statins
(IN BRIEF) Researchers from the Brain Repair laboratory at the University of Helsinki have investigated whether a protein called cerebral dopamine neurotrophic factor (CDNF) has potential as a treatment for intracerebral haemorrhage, a condition where bleeding into brain tissue causes … Read the full press release
Posted in Education, Finland, Healthcare, Management, News, Pharma & Biotech, Science
Tagged brain hemorrhage, cerebral dopamine neurotrophic factor (CDNF), Dr. Vassileios Stratoulias, intracerebral haemorrhage, Mikko Airavaara, Parkinson's disease, protein, protein therapy, researchers, treatment, University of Helsinki
(IN BRIEF) Sanofi has agreed to acquire Provention Bio, a U.S.-based biopharmaceutical company focused on preventing and intercepting immune-mediated diseases, for $2.9 billion. The acquisition includes Provention Bio’s first-in-class therapy for type 1 diabetes, TZIELD, which was approved in the … Read the full press release
(IN BRIEF) Merck and Intel have signed a memorandum of understanding to invest in a new academic research program aimed at driving innovation in semiconductor manufacturing processes and technologies using artificial intelligence (AI) and machine learning. The companies will jointly … Read the full press release
Posted in Artificial Intelligence (AI), Education, Environment, Germany, Healthcare, News, Pharma & Biotech, Science
Tagged artificial intelligence (AI), David Nessim, Dr. Beate Burkhart, Europe, Intel, Machine Learning, Manufacturing, Merck, partnership, RESEARCH, semiconductor, sustainable, technology
(IN BRIEF) Sandoz, a global leader in generic and biosimilar medicines, has signed a Memorandum of Understanding to build a new biologics production plant in Lendava, Slovenia, in a move expected to be worth at least USD 400 million. The … Read the full press release
Posted in Business, Financial, Healthcare, Investment, Management, News, Pharma & Biotech, Science, Switzerland
Tagged antibiotics, Biologics Plant, Dr Robert Golob, Glenn Gerecke, investment, Lendava, Novartis, partnership, Richard Saynor, Sandoz, Slovenia
(ACTUALITÉ EN BREF) AstraZeneca a lancé le Défi postdoctoral R&D 2023, qui invite les étudiants en dernière année de médecine et/ou de doctorat et les chercheurs postdoctoraux du monde entier à soumettre leurs propres propositions de recherche. L’initiative est conçue … Read the full press release
(IN BRIEF) AstraZeneca has launched the 2023 R&D Postdoctoral Challenge, which invites final-year MD and/or PhD students and postdoctoral researchers from around the world to submit their own research proposals. The initiative is designed to promote diversity of thought and … Read the full press release
(IN BRIEF) QIAGEN has entered into a partnership with global pharmaceutical group, Servier, to develop a companion diagnostic test for TIBSOVO, an isocitrate dehydrogenase-1 (IDH1) inhibitor used to treat acute myeloid leukemia (AML). QIAGEN will develop and validate a real-time … Read the full press release
(IN KÜRZE) Die University of Liverpool und die Global Antibiotic Research and Development Partnership (GARDP) haben eine Absichtserklärung unterzeichnet, um bei neuen Projekten zur Bekämpfung der Antibiotikaresistenz (AMR) zusammenzuarbeiten. Sie arbeiten seit 2018 zusammen, um neue Behandlungsmöglichkeiten für Neugeborene mit … Read the full press release
Posted in Education, Healthcare, Non Profit, Pharma & Biotech, Science, Switzerland, Technology, United Kingdom
Tagged AMR, Antimikrobielle Chemotherapie-Konferenz, antimikrobielle Resistenz, arzneimittelresistente Infektionen, Arzneimittelresistenz, Dame Sally Davies, GARDP, Global Antibiotic Research and Development Partnership, Neugeborene, Professor William Hope, Seamus O’Brien, SEPSIS, the University of Liverpool
(IN BRIEF) The University of Liverpool and the Global Antibiotic Research and Development Partnership (GARDP) have signed a Memorandum of Understanding to collaborate on new projects to address antimicrobial resistance (AMR). They have been working together since 2018 to advance … Read the full press release
Posted in Education, Healthcare, Non Profit, Pharma & Biotech, Science, Switzerland, Technology, United Kingdom
Tagged AMR, Antimicrobial Chemotherapy Conference, antimicrobial resistance, Dame Sally Davies, drug resistance, drug-resistant infections, GARDP, Global Antibiotic Research and Development Partnership, newborns, Professor William Hope, Seamus O’Brien, SEPSIS, the University of Liverpool
(IN BRIEF) Specialty chemicals company Evonik has opened a lipid launch facility at its site in Hanau, Germany. The good manufacturing practice facility, which opened on 8 March 2023, will enable Evonik to provide customers with quantities of lipids as … Read the full press release
Posted in Chemicals, Germany, Healthcare, News, Pharma & Biotech, Science
Tagged drug delivery, Evonik, health, health care, lipid, Nutrition, Paul Spencer, PhytoChol®, Thomas Riermeier
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?